Prakash M. Patil
#833Chairman, Managing Director & CEO
53
Age
31y
Exp
41y
Tenure
5/10
Risk
🎓 B.E. Chemical · Institute of Chemical Technology
📜 M.E. · Institute of Chemical Technology (ICT), Mumbai (Chemical Engineering)
🏛️ None
CompensationTBP
Personality
5
Open
8
Cons
4
Extr
5
Agre
4
Neur
Aarti Drugs
Healthcare · Small Cap
Mature Stable · Hierarchical
About
Prakash M. Patil is the Chairman, Managing Director & CEO of Aarti Drugs, a Small Cap company in the Healthcare sector with a market cap of ₹3K Cr. A Transactional leader with 31 years of experience, he is known for authority-driven decision-making and organic builder strategy. Prioritizes steady backward integration and process efficiencies in the API manufacturing sector with a clear focus on bottom-line results.
FAQ
What is Prakash M. Patil's leadership style?
Prakash M. Patil is classified as a Transactional leader. He is authority-driven in decision-making, with a empire expander motivation and steady-marathon pace of execution.
What is Prakash M. Patil's educational background?
Prakash M. Patil holds a B.E. Chemical from Institute of Chemical Technology and a M.E. from Institute of Chemical Technology (ICT), Mumbai (Chemical Engineering).
Who is the CEO of Aarti Drugs?
Prakash M. Patil is the Chairman, Managing Director & CEO of Aarti Drugs. He has been with the company for 41 years and in the current role for 11 years.
Leadership DNA
ArchetypeTransactional
MotivationEmpire Expander
CrisisCost Cutter
DecisionAuthority-Driven
GrowthOrganic Builder
PeopleNumbers Driven
InnovationFast-Follower
PaceSteady-Marathon
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployerSteady Employer
BrandTechnical-Expert
FocusOperational Excellence
OrientationDeep Specialist
Leadership Evidence
“Prioritizes steady backward integration and process efficiencies in the API manufacturing sector with a clear focus on bottom-line results.”
⚡ Crisis●●●●○
Patil consistently prioritizes operational efficiency and margin protection through strict cost control measures in the competitive API manufacturing sector.
🎯 Motivation●●●●○
He has focused on aggressive capacity expansion and horizontal integration to maintain Aarti Drugs' dominance in the global API market.
👥 People●●●●○
His management style is characterized by a strong focus on operational excellence and data-driven performance metrics typical of a transactional leader.
📈 Growth●●●●●
Aarti Drugs' growth has been primarily driven by continuous capacity additions and debottlenecking of existing manufacturing facilities.
💡 Innovation●●●●○
The company focuses on scaling production of established Active Pharmaceutical Ingredients (APIs) and generic formulations rather than pioneering new drug discovery.
🏃 Pace●●●●○
The company has maintained a consistent, long-term growth trajectory in the API and intermediate chemicals space through methodical capacity expansion.
🌱 Purpose●●●●○
Corporate strategy is primarily centered on cost-efficient manufacturing and market share expansion in the API segment with standard statutory CSR compliance.
🏷️ Brand●●●●○
The company is recognized in the industry for its deep technical expertise in complex chemical synthesis and large-scale API manufacturing processes.
🤝 Customer●●●●●
Aarti Drugs operates primarily as a B2B supplier of APIs and intermediates to other pharmaceutical companies and global healthcare enterprises.
💼 Employer●●●○○
As a mature manufacturing-led organization, it offers a stable, process-oriented work environment typical of the Indian chemical and pharmaceutical manufacturing sector.
📋 Mandate
As an API manufacturer, the company must focus on stringent global regulatory compliance and risk mitigation to navigate global supply chain shifts.
🏢 Culture●●●○○
Mature manufacturing company with centralized leadership under long-tenured promoter management.
Financials
Revenue FY25₹2K Cr
PAT FY25₹168 Cr
Rev CAGR 5Y-1.6%
OPM10.3%
NPM7.1%
ROE12.3%
ROCE14%
P/E15.7
Fwd P/E14.1
P/B2.3
D/E39
Promoter61.2%
Institutional11.1%
Mkt Cap₹3K Cr
Compensation
To Be Published
Data being verified from audited reports
